HIVE Digital Technologies Ltd., a green-energy Bitcoin mining and high-performance computing (HPC) company, has endured a steep drawdown from its 52-week high of roughly $6.30. With the stock trading near $1.98, the question on many investors' minds is whether it can rebuild toward the $7.00 level that dominates much of the current sell-side coverage.
The current analyst price targets are unusually dispersed, which is typical of Bitcoin-linked equities whose fortunes track cryptocurrency prices. Reviewed targets range from approximately $4.50 (Cantor Fitzgerald, Overweight) to $10.00 (Canaccord Genuity, Buy, most recently reaffirmed in October 2026). In between sit HC Wainwright at $7.00 (Buy), Chardan Capital at $7.50 (Buy), B. Riley at $8.00 (Buy), Rosenblatt at $6.00 (Buy), and Keefe, Bruyette & Woods at $5.00 (Market Perform).
Averaging these verified, current targets yields roughly $6.90, which rounds to the $7.00 central target used throughout this article — essentially in line with the $6.95 consensus tracked independently by MarketBeat. The divergence among analysts matters: bulls emphasize recurring AI revenue, while the more cautious firms focus on valuation and Bitcoin exposure. Notably, Weiss Ratings and Wall Street Zen have carried sell ratings on the shares, underscoring that this is not a uniformly bullish setup.
The stock last traded near $1.98, close to its 52-week low of $1.73 and far below the $6.30 high. A move to $7.00 therefore implies upside of about 250%, which must be described as very large rather than modest. HIVE's market capitalization is roughly $550 million, and the company carries a beta near 3.8, meaning its shares are considerably more volatile than the broader market.
The plausible path toward the target rests on a dual narrative: sustained or rising Bitcoin prices lifting mining economics, combined with the HPC segment scaling into a predictable, recurring revenue stream. HIVE reported fiscal first-quarter 2027 revenue of $79.1 million (up about 74% year over year) but still posted a net loss, with EPS (earnings per share) of -$0.54, below consensus expectations. A credible move toward $7.00 would likely require the market to begin valuing the stock on its growing HPC backlog rather than on current mining cash flows.
HIVE is trading below its 50-day and 200-day moving averages, which sit in the high $2 and low $3 range, respectively — a bearish long-term structure. Durable support is the 52-week low near $1.73, with the $2.00 psychological level serving as a nearer reference. On the upside, the prior high around $6.30 is the most significant resistance zone, and the $7.00 target would require clearing that former peak entirely. Until the stock reclaims its longer-term averages, the technical picture remains defensive.
Analyst price targets generally reflect a roughly 12-month research horizon, though no single timeline was stated across the firms reviewed. Investors should watch quarterly earnings and EPS trends, updates on the $350 million GPU contract and HPC annualized revenue, Bitcoin price movements and network difficulty, and any further analyst target revisions. Company-specific items such as financing announcements and insider transactions also carry weight, given HIVE's capital needs.
For traders seeking a more systematic view of HIVE's shifting momentum, Tickeron's AI Daily Buy/Sell Signals offer a useful complement to fundamental research. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. This can help traders discover opportunities, monitor existing positions, and spot emerging trends more efficiently than manual screening alone. Those interested in adding an AI layer to their HIVE analysis may find the signals a practical starting point.
Whether HIVE can reach $7.00 depends on a convergence of crypto strength and successful AI infrastructure execution. The target reflects the average analyst price target near $6.90, rounded to $7.00, with a wide range of $4.50 to $10.00 that signals genuine disagreement. The roughly 250% move required is very large and would mean fully recovering from the stock's steep decline and pushing beyond its prior high. The $350 million GPU contract and expanding HPC revenue provide a credible, if unproven, growth engine, while ongoing losses, Bitcoin dependence, and financing risk remain the principal obstacles. No outcome is assured, and investors should treat the target as a research reference rather than a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HIVE has been closely correlated with CLSK. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if HIVE jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To HIVE | 1D Price Change % | ||
|---|---|---|---|---|
| HIVE | 100% | -3.94% | ||
| CLSK - HIVE | 77% Closely correlated | -6.86% | ||
| KEEL - HIVE | 76% Closely correlated | -6.67% | ||
| CIFR - HIVE | 73% Closely correlated | -8.87% | ||
| BTBT - HIVE | 73% Closely correlated | -3.73% | ||
| COIN - HIVE | 73% Closely correlated | -4.51% | ||
More | ||||